#skymap-pharma
Centre clears IMPCL disinvestment as Skymap Pharma emerges highest bidder
Government approves IMPCL strategic sale to Skymap Pharmaceuticals for Rs 121 crore under competitive bidding as part of India’s disinvestment plan.
Government okays Skymap Pharmaceuticals' Rs 121-cr bid to buy IMPCL
The government has approved the sale of Indian Medicines Pharmaceutical Corporation Ltd. Skymap Pharmaceuticals Pvt Ltd will acquire the company for over Rs 121 crore. This strategic sale involves 100 percent stake and management control. IMPCL manufactures A…